May 14, 2020 / 11:24 AM / 18 days ago

BRIEF-Frequency Therapeutics Shares Clinical Data From Exploratory Study Confirming Delivery Of FX-322 To The Cochlea

May 14 (Reuters) - Frequency Therapeutics Inc:

* FREQUENCY THERAPEUTICS SHARES CLINICAL DATA FROM EXPLORATORY STUDY CONFIRMING DELIVERY OF FX-322 TO THE COCHLEA

* FREQUENCY THERAPEUTICS INC - TOP-LINE RESULTS SHOW CONSISTENT DRUG ENTRY IN ALL PATIENTS

* FREQUENCY THERAPEUTICS INC - STUDY RESULTS SHOWED MEASURABLE CONCENTRATIONS OF FX-322 IN EVERY PATIENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below